How We WorkOrder NowSupport Privacy

Volume Buzzers: BroadSoft Inc. (NASDAQ:BSFT) and Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)

on 26/03/2013

New York, NY – (Net PR News) – 03/26/2013 –smartOTCis the premiere destination for Investors and novices alike who wish to receive information on fast moving OTC stocks and undiscovered companies. Most of these companies are considered penny stocks and trade on the Pink Sheet or OTC BB market. Our daily alerts help investors cut their research time in half as we send out small cap and penny stock alerts that are displaying signs of a potential rally.

Sign up For Our No. 1 Rated Stock Newsletter to make Huge Profits http://www.smartotc.com

SmartOTC brings a special trend analysis of these stocks:BroadSoft Inc. (NASDAQ:BSFT) and Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)

Raymond James lifted its rating on the stock of BroadSoft Inc. (NASDAQ:BSFT) on Tuesday morning to “Market Perform” from “Underperform.”

BroadSoft stock rallied after the opening bell on Tuesday and is now higher 2.13, at $29.02, in the early session. The stock has increased to a one-month high.

A lot of other companies have also lately given remarks on BSFT. Experts at Pacific Crest lowered their price target on stock of Broadsoft from $38.00 to $36.00 in a research memo given to investors on Thursday, February 28th.

What other experts have gave remarks about Broadsoft? Find out here

Separately, experts at Needham & Company lowered their price target on stock of Broadsoft(BSFT), from $40.00 to $30.00 in a research memo to investors on Thursday, February 28th. They now keep a “buy” rating on the stock. And last, experts at Goldman Sachs lowered their price target on stock of Broadsoft to $38.00 in a research note to investors on Thursday, February 28th.

How shares of Progenics Pharmaceuticals attracted investors on Tuesday? Find out in this report

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) witnessed its shares rallying 28.99%, or $0.98 per share, to end at $4.36 on volume of 4,013,231 shares exchanged in Friday’s trading session.

Shares of Progenics Pharmaceuticals, Inc. rallied Friday following the firm declared its fourth-quarter loss declined, enhanced by lowered costs.

The firm’s performance easily topped Wall Street’s targets.

About Us:

smartOTC is the premiere destination for Investors and novice alike who wish to receive information on fast moving OTC penny stocks and undiscovered companies. We are a marketing firm that releases paid reports on undiscovered companies looking to tell their stories. Most of these companies are considered penny stocks and trade on the Pink Sheet or OTC BB market. Our daily alerts help investors cut their research time in half as we send out small cap and penny stock alerts that are displaying signs of a potential rally.

 

While penny stocks pose a much more significant risk factor compared to large cap stocks, their lure of quick gains makes it a trading choice for many small time and beginner investors. There is nothing wrong with investments into penny stocks, the best advice is to do your own research and consult with your own financial professional. smartOTC reports and alerts should only be used as a starting point for your own due diligence.

Disclaimer:

PLEASE NOTE WELL: This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.

Smartotc.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The disclaimer is to be read and fully understood before using our site, or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.

Read Our Full Disclaimer at http://www.smartotc.com/disclaimer

Source: smartotc Posted Tue, March 26, 2013 17:43 - Permalink